Cleared Traditional

K212069 - Corin MetaFix™ Hip Stem

K212069 is an FDA 510(k) clearance for Corin MetaFix Hip Stem, manufactured by Corin U.S.A. Limited. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 279-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
279d
Days
Class 2
Risk

K212069 is an FDA 510(k) clearance for the Corin MetaFix™ Hip Stem. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Corin U.S.A. Limited (Tampa, US). The FDA issued a Cleared decision on April 7, 2022 after a review of 279 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Corin U.S.A. Limited devices

FDA 510(k) Submission Details - K212069

510(k) Number K212069 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2021
Decision Date April 07, 2022
Days to Decision 279 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
157d slower than avg
Panel avg: 122d · This submission: 279d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 507
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K212069.
M-Vizion Monobloc
K212327 · Medacta International S.A. · May 2022
Amis K Long
K220405 · Medacta International S.A. · Apr 2022
MP Reconstruction System
K213675 · Waldemar Link GmbH & Co. KG · Apr 2022
DePuy Corail AMT Hip Prosthesis
K213839 · DePuy Orthopaedics, Inc. · Jan 2022
Restoration Modular 115mm Conical Distal Stem
K213129 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Dec 2021
Adapter Sleeve for BIOLOX® OPTION Femoral Head, +10.5mm head length
K213580 · Total Joint Othopedics, Inc. · Dec 2021